Welcome!

News Feed Item

SHL Telemedicine Reports Second Quarter 2014 Financial Results

-- Revenue increased 39.2% to USD 10.3 million (USD 7.4 million in Q2 2013)

TEL AVIV, Israel and ZURICH, Aug. 20, 2014 /PRNewswire/ -- SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN, OTCPK: SMDCY), a leading provider and developer of advanced personal telemedicine solutions, today announced results for the second quarter and six months ended 30 June 2014.

Erez Alroy, Co-CEO of SHL, commented: "We have seen good momentum in our businesses leading to significantly improved financial performance for the period, even with the increased investments in our expansion initiatives. Expansion into new markets beyond Israel and Germany, based on our global smartheart™ platform, remains a key priority for SHL's growth strategy.

"In the US, we are progressing with our plans to launch our products and services, while in India we have made first steps in rolling out our telemedicine solution. In addition, since receiving approval in March to commence marketing activities in Japan, our smartheart™ platform has been accepted by over 20 leading Japanese clinics.

"We have gone through a lengthy process of receiving regulatory and marketing approvals for the smartheart™ platform in several major territories. The global interest we are witnessing is very encouraging and we are excited by the opportunities it may bring."

Financial Highlights
During the second quarter 2014, revenues increased considerably primarily due to the growth in the Company's German business, following the acquisition of almeda. Even with the increased investments in geographical expansion, SHL's financial performance has improved significantly with improved gross profit and operating results.

Revenues for the quarter grew by 39.2% (32.4% at constant exchange rates*) and amounted to USD 10.3 million compared to USD 7.4 million in Q2 2013.

For the half year revenues grew by 44.1% (37.2% at constant exchange rates) and amounted to USD 20.9 million compared to USD 14.5 million in the first half of 2013.

Gross profit for the quarter amounted to USD 5.8 million (56.3% of revenues) compared to USD 3.9 million (52.7% of revenues) in Q2 2013. Gross profit for the half year amounted to USD 11.7 million (56.0% of revenues) compared to a gross profit of USD 7.6 million (52.4% of revenues) in the first half of 2013.

EBITDA and EBIT for the half year and second quarter improved significantly over the adjusted EBITDA and EBIT of 2013, which included a one-time item lowering the general and administrative expenses.

For the quarter, EBITDA amounted to USD 1.7 million (16.5% of revenues) with EBIT at USD 0.2 million (1.9% of revenues) compared with an adjusted EBITDA and LBIT of USD 0.6 million and USD 0.7 million in the second quarter 2013.

For the half year, EBITDA amounted to USD 3.7 million (17.7% of revenues) with an EBIT of USD 0.6 million (2.9% of revenues), compared with an adjusted EBITDA of USD 0.5 million (3.4% of revenues) and an LBIT of USD 1.9 million in the first half of 2013.

Unadjusted EBITDA and EBIT for the second quarter 2013 amounted to USD 1.7 million and USD 0.4 million, respectively with EBITDA and EBIT for the first half of 2013 amounting to USD 3.1 million and USD 0.6 million, respectively.

Net Income for the quarter and half year was USD 0.1 million, or USD 0.01 per share, compared to an adjusted net loss of USD 1.1 million, for the second quarter 2013 and USD 2.8 million for the first half of 2013. Unadjusted net profit for the second quarter and first half of 2013 amounted to USD 0.1 million (USD 0.00 per share) and USD 0.3 million (USD 0.03 per share), respectively.

Cash used in operations for the quarter and half year amounted to USD 0.9 million and USD 3.3 million, respectively. Excluding USD 5.2 million received from Philips in the first quarter of 2013, which was the last payment related to the Raytel transaction, cash used in operations during the quarter and half year 2013 amounted to USD 0.8 million and USD 2 million. The decrease in operating cash flow is the result of one–time working capital requirements at almeda, for which SHL received USD 2.9 million upfront at the end of 2013. Cash, cash equivalents and marketable securities amounted to USD 21.8 million at June 30, 2014.

Balance sheet included total assets at 30 June 2014 of USD 106.3 million with shareholders' equity amounting to USD 68.8 million (64.7% of balance sheet) compared to total assets of USD 108.5 million with shareholders' equity amounting to USD 68.9 million at 31 December 2013.

SHL Telemedicine – consolidated key figures – Q2 2014

in USD million
(except per
share amounts)

Q2 2014

Q2 2013

% change

Q2 2014
(constant
currency)

% change

Revenues

10.3

7.4

39.2%

9.8

32.4%

Gross profit

5.8

3.9

48.7%

5.5

41.0%

%

56.3%

52.7%


56.1%


EBIT/(LBIT)

0.2

0.4

(50.0%)

0.2

(50.0%)

%

1.9%

5.4%


2.0%


EBITDA

1.7

1.7

0.0%

1.6

(5.9%)

%

16.5%

23.0%


16.3%


Net income
(loss)

0.1

0.1

n.a.

0.1

n.a.

Basic EPS
(LPS)

0.01

0.00

n.a.

0.01

n.a.

SHL Telemedicine – consolidated key figures - H1 2014

in USD million
(except per
share amounts)

H1 2014

H1 2013

% change

H1 2014
(constant
currency)

% change

Revenues

20.9

14.5

44.1%

19.9

37.2%

Gross profit

11.7

7.6

53.9%

11.2

47.4%

%

56.0%

52.4%


56.3%


EBIT/(LBIT)

0.6

0.6

0.0%

0.6

0.0%

%

2.9%

4.1%


3.0%


EBITDA

3.7

3.1

19.4%

3.5

12.9%

%

17.7%

21.4%


17.5%


Net income
(loss)

0.1

(0.3)

n.a.

0.1

n.a.

Basic EPS
(LPS)

0.01

(0.03)

n.a.

0.01

n.a.

*Constant currency - In order to enable meaningful comparison between the results, they are also presented at constant currency exchange rates. These are calculated by translating the 2014 results using the average 2013 exchange rates instead of the current period exchange rates.

Management believes that this presentation enables a more meaningful comparison between the periods due to the significant fluctuations in NIS/USD/EUR exchange rates.

Revenues by geographic distribution – Q2 14


Israel

Germany


USD m

% of total

USD m

% of total

Q2 2014

6.1

59.2%

4.2

40.8%

Q2 2013

5.8

78.4%

1.6

21.6%

Q2 2014 (in constant
currency)

5.9

60.2%

3.9

39.8%

% change in constant
currency

1.7%


143.8%



Revenues by geographic distribution – H1 14


Israel

Germany


USD m

% of total

USD m

% of total

H1 2014

12.2

58.4%

8.7

41.6%

H1 2013

11.4

78.6%

3.1

21.4%

H1 2014 (in constant
currency)

11.6

58.3%

8.3

41.7%

% change in constant
currency

1.8%


167.7%


Conference Call, today, 4.00 pm CET / 10.00am ET 
SHL will hold a call to discuss the Q2 results today at 4.00 pm CET / 10.00am ET. Erez Alroy, Co-CEO, and Eran Antebi, CFO, will host the call. Dial-in numbers are as follows:

From Europe

+41 (0)58 310 50 00

From UK

+44 (0)203 059 58 62

From U.S.A.

Toll free: +1 866 291 41 66

From Israel

Toll free: 1 80 921 44 27


Local: +972 3763 1173

Slides and our half year report are available at
http://www.shl-telemedicine.com/about-us/investorrelations/financial-reports-pres-2014/

IR Agenda 2014
November 19, 2014    Q3 Results

About SHL Telemedicine

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. The Company operates in Israel, Germany, India and the United States in one business segment, Telemedicine services. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and has an ADR program listed over-the counter; Symbol: SMDCY. For more information please visit our web site at www.shl-telemedicine.com.

For further information please contact:

Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.

 

Balance-Sheets (USD thousands)

30.6.2014

30.6.2013

31.12.2013


Unaudited

Unaudited

Audited

Cash and cash equivalents

8,154

9,457

8,732

Restricted cash

1,365

-

-

Short term investments

12,301

18,091

19,661

Trade receivables

14,764

12,495

10,479

Inventory

1,628

475

869

Other current assets

8,193

6,596

8,014

Current Assets

46,405

47,114

47,755





Non-Current Assets

11,403

12,322

11,632





Property and equipment, net

15,700

15,125

15,982





Intangible assets, net

32,793

23,292

33,146

Total Assets

106,301

97,853

108,515





Credit from banks and current maturities

10,643

9,117

10,477

Deferred revenues

521

110

330

Trade payables

1,969

1,016

1,433

Other accounts payable

4,236

3,768

4,568

Other liabilities

1,526

-

2,504

Current liabilities

18,895

14,011

19,312





Long-term loans

16,496

18,965

18,205

Deferred revenues

1,218

1,272

1,283

Employee benefit liabilities

875

985

805

Non-current liabilities

18,589

21,222

20,293





Total liabilities

37,484

35,233

39,605

Equity:




Issued capital

31

31

31

Additional paid-in capital

95,037

94,692

95,014

Treasury shares

(2,579)

(2,956)

(2,774)

Foreign currency translation reserve

6,213

3,622

6,148

Capital reserve for available-for-sale 
     investments and actuarial gains

1,175

892

1,633

Accumulated deficit

(31,060)

(33,661)

(31,142)

Total equity

68,817

62,620

68,910

Total liabilities and equity

106,301

97,853

108,515

 

 

Statements of Income
(USD thousands, except per share data)

Q2 14

Q2 13

H1 14

H1 13

2013


Unaudited

Unaudited

Unaudited

Unaudited

Audited

Revenues

10,274

7,408

20,917

14,548

29,674







Depreciation and amortization

562

551

1,166

1,122

2,127

Cost of revenues

3,947

2,963

8,007

5,859

11,607

Gross Profit

5,765

3,894

11,744

7,567

15,940







Research and development costs, net

645

577

1,242

1,013

2,206

Selling and marketing expenses

2,987

2,328

5,719

4,679

8,787

General and administrative expenses

2,063

583

4,347

1,291

10,341

Gain from almeda acquisition and other income

(137)

-

(137)

-

(8,492)

Operating income

207

406

573

584

3,098







Financial income

511

141

704

474

1,072

Financial expenses

(370)

(407)

(614)

(1,052)

(2,631)

Income before taxes on income

348

140

663

6

1,539

Taxes on income (Tax benefit)

269

82

581

293

(693)







Net income (loss)

79

58

82

(287)

2,232







Basic and diluted income (loss) per share

0.01

0.00

0.01

(0.03)

0.22


Other Comprehensive income not to be 
     reclassified to profit or loss in subsequent 
     periods:






Foreign currency translation reserve

301

620

65

1,562

4,088

Actuarial gain

-

-

-

-

233


301

620

65

1,562

4,321

Other Comprehensive income to be reclassified 
     to profit or loss in subsequent periods






Transfer to the statement of income in respect of 
     available-for-sale investments

(489)

 

13

(545)

 

(19)

146

Gain (loss) on available-for-sale investments

(87)

19

87

63

406


(576)

32

(458)

44

552













Total comprehensive income (loss)

(196)

710

(311)

1,319

7,105







 

 

Statements of Cash Flows (USD thousands)

Q2 2014

Q2 2013

H1 2014

H1 2013

2013


Unaudited

Unaudited

Unaudited

Unaudited

Audited

Net income (loss)

79

58

82

(287)

2,232

Adjustment required to reconcile net income 
     (loss) to net cash provided by (used in) 
     operating activities

(964)

 

 

(822)

(3,340)

 

 

3,459

400

Net Cash provided by (used in) Operating 
     Activities

(885)

(764)

(3,258)

3,172

2,632







Purchase of property and equipment

(480)

(315)

(863)

(918)

(2,200)

Investment in intangible assets

(380)

(501)

(778)

(986)

(1,878)

Restricted cash

(1,367)

-

(1,367)



Acquisition of almeda

-

-

-

-

2,920

Proceeds from sale of property and 
     equipment

-

 

14

-

 

14

29

Purchase of short-term investments

(3,130)

(2,665)

(5,056)

(3,113)

(8,511)

Proceeds from sale of  short-term investments

10,085

 

905

12,529

 

1,654

6,402

Net Cash provided by (used in) Investing 
     Activities

4,728

(2,562)

4,465

(3,349)

(3,238)







Proceeds from exercise of options

60

101

65

141

486

Short-term bank credit, net

(714)

461

-

218

1,053

Payment of long-term loans

(998)

(804)

(1,867)

(1,580)

(3,267)

Treasury shares purchased

-

-

-

(36)

(36)

Net Cash used in Financing Activities

(1,652)

(242)

(1,802)

(1,257)

(1,764)

Effect of exchange rate changes on cash and 
     cash equivalents

24

 

56

17

 

278

489

Increase (decrease) in cash and cash 
     equivalents

2,215

(3,512)

(578)

(1,156)

(1,881)

Cash and cash equivalents at the beginning of 
     the period

5,939

12,969

8,732

10,613

10,613

Cash and Cash equivalents at the end of the 
     period

8,154

9,457

8,154

9,457

8,732

 

SOURCE SHL Telemedicine Ltd.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
I wanted to gather all of my Internet of Things (IOT) blogs into a single blog (that I could later use with my University of San Francisco (USF) Big Data “MBA” course). However as I started to pull these blogs together, I realized that my IOT discussion lacked a vision; it lacked an end point towards which an organization could drive their IOT envisioning, proof of value, app dev, data engineering and data science efforts. And I think that the IOT end point is really quite simple…
Internet of @ThingsExpo, taking place November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 19th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devices - comp...
StarNet Communications Corp has announced the addition of three Secure Remote Desktop modules to its flagship X-Win32 PC X server. The new modules enable X-Win32 to safely tunnel the remote desktops from Linux and Unix servers to the user’s PC over encrypted SSH. Traditionally, users of PC X servers deploy the XDMCP protocol to display remote desktop environments such as the Gnome and KDE desktops on Linux servers and the CDE environment on Solaris Unix machines. XDMCP is used primarily on comp...
Traditional on-premises data centers have long been the domain of modern data platforms like Apache Hadoop, meaning companies who build their business on public cloud were challenged to run Big Data processing and analytics at scale. But recent advancements in Hadoop performance, security, and most importantly cloud-native integrations, are giving organizations the ability to truly gain value from all their data. In his session at 19th Cloud Expo, David Tishgart, Director of Product Marketing ...
SYS-CON Events announced today that eCube Systems, a leading provider of middleware modernization, integration, and management solutions, will exhibit at @DevOpsSummit at 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. eCube Systems offers a family of middleware evolution products and services that maximize return on technology investment by leveraging existing technical equity to meet evolving business needs. ...
The 19th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Digital Transformation, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportuni...
DevOps at Cloud Expo, taking place Nov 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 19th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long dev...
Aspose.Total for .NET is the most complete package of all file format APIs for .NET as offered by Aspose. It empowers developers to create, edit, render, print and convert between a wide range of popular document formats within any .NET, C#, ASP.NET and VB.NET applications. Aspose compiles all .NET APIs on a daily basis to ensure that it contains the most up to date versions of each of Aspose .NET APIs. If a new .NET API or a new version of existing APIs is released during the subscription peri...
Data is the fuel that drives the machine learning algorithmic engines and ultimately provides the business value. In his session at Cloud Expo, Ed Featherston, a director and senior enterprise architect at Collaborative Consulting, will discuss the key considerations around quality, volume, timeliness, and pedigree that must be dealt with in order to properly fuel that engine.
SYS-CON Events announced today that StarNet Communications will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. StarNet Communications’ FastX is the industry first cloud-based remote X Windows emulator. Using standard Web browsers (FireFox, Chrome, Safari, etc.) users from around the world gain highly secure access to applications and data hosted on Linux-based servers in a central data center. ...
SYS-CON Events announced today that Hitrons Solutions will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Hitrons Solutions Inc. is distributor in the North American market for unique products and services of small and medium-size businesses, including cloud services and solutions, SEO marketing platforms, and mobile applications.
Pulzze Systems was happy to participate in such a premier event and thankful to be receiving the winning investment and global network support from G-Startup Worldwide. It is an exciting time for Pulzze to showcase the effectiveness of innovative technologies and enable them to make the world smarter and better. The reputable contest is held to identify promising startups around the globe that are assured to change the world through their innovative products and disruptive technologies. There w...
As the world moves toward more DevOps and Microservices, application deployment to the cloud ought to become a lot simpler. The Microservices architecture, which is the basis of many new age distributed systems such as OpenStack, NetFlix and so on, is at the heart of Cloud Foundry - a complete developer-oriented Platform as a Service (PaaS) that is IaaS agnostic and supports vCloud, OpenStack and AWS. Serverless computing is revolutionizing computing. In his session at 19th Cloud Expo, Raghav...
Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more business becomes digital the more stakeholders are interested in this data including how it relates to business. Some of these people have never used a monitoring tool before. They have a question on their mind like “How is my application doing” but no id...
Personalization has long been the holy grail of marketing. Simply stated, communicate the most relevant offer to the right person and you will increase sales. To achieve this, you must understand the individual. Consequently, digital marketers developed many ways to gather and leverage customer information to deliver targeted experiences. In his session at @ThingsExpo, Lou Casal, Founder and Principal Consultant at Practicala, discussed how the Internet of Things (IoT) has accelerated our abil...